Global Next Generation Cancer Diagnostics Market Research Report 2023

Report ID: 1912286 | Published Date: Jan 2025 | No. of Page: 104 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Next Generation Sequencing
        1.2.3 qPCR & Multiplexing
        1.2.4 DNA Microarrays
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Next Generation Cancer Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Next Generation Cancer Diagnostics Market Perspective (2017-2028)
    2.2 Next Generation Cancer Diagnostics Growth Trends by Region
        2.2.1 Next Generation Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Next Generation Cancer Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Next Generation Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Next Generation Cancer Diagnostics Market Dynamics
        2.3.1 Next Generation Cancer Diagnostics Industry Trends
        2.3.2 Next Generation Cancer Diagnostics Market Drivers
        2.3.3 Next Generation Cancer Diagnostics Market Challenges
        2.3.4 Next Generation Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Next Generation Cancer Diagnostics Players by Revenue
        3.1.1 Global Top Next Generation Cancer Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Next Generation Cancer Diagnostics Revenue
    3.4 Global Next Generation Cancer Diagnostics Market Concentration Ratio
        3.4.1 Global Next Generation Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostics Revenue in 2021
    3.5 Next Generation Cancer Diagnostics Key Players Head office and Area Served
    3.6 Key Players Next Generation Cancer Diagnostics Product Solution and Service
    3.7 Date of Enter into Next Generation Cancer Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Cancer Diagnostics Breakdown Data by Type
    4.1 Global Next Generation Cancer Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2023-2028)
5 Next Generation Cancer Diagnostics Breakdown Data by Application
    5.1 Global Next Generation Cancer Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Next Generation Cancer Diagnostics Market Size (2017-2028)
    6.2 North America Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
    6.3 North America Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Next Generation Cancer Diagnostics Market Size (2017-2028)
    7.2 Europe Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
    7.3 Europe Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Next Generation Cancer Diagnostics Market Size (2017-2028)
    9.2 Latin America Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
    9.3 Latin America Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Cepheid
        11.1.1 Cepheid Company Detail
        11.1.2 Cepheid Business Overview
        11.1.3 Cepheid Next Generation Cancer Diagnostics Introduction
        11.1.4 Cepheid Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.1.5 Cepheid Recent Development
    11.2 Koninklijke Philips N.V
        11.2.1 Koninklijke Philips N.V Company Detail
        11.2.2 Koninklijke Philips N.V Business Overview
        11.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Introduction
        11.2.4 Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.2.5 Koninklijke Philips N.V Recent Development
    11.3 F. Hoffmann-La Roche Ltd
        11.3.1 F. Hoffmann-La Roche Ltd Company Detail
        11.3.2 F. Hoffmann-La Roche Ltd Business Overview
        11.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Introduction
        11.3.4 F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.3.5 F. Hoffmann-La Roche Ltd Recent Development
    11.4 Qiagen
        11.4.1 Qiagen Company Detail
        11.4.2 Qiagen Business Overview
        11.4.3 Qiagen Next Generation Cancer Diagnostics Introduction
        11.4.4 Qiagen Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.4.5 Qiagen Recent Development
    11.5 Novartis AG
        11.5.1 Novartis AG Company Detail
        11.5.2 Novartis AG Business Overview
        11.5.3 Novartis AG Next Generation Cancer Diagnostics Introduction
        11.5.4 Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.5.5 Novartis AG Recent Development
    11.6 Abbott
        11.6.1 Abbott Company Detail
        11.6.2 Abbott Business Overview
        11.6.3 Abbott Next Generation Cancer Diagnostics Introduction
        11.6.4 Abbott Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.6.5 Abbott Recent Development
    11.7 Thermo Fisher Scientific
        11.7.1 Thermo Fisher Scientific Company Detail
        11.7.2 Thermo Fisher Scientific Business Overview
        11.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Introduction
        11.7.4 Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.7.5 Thermo Fisher Scientific Recent Development
    11.8 Opko Health
        11.8.1 Opko Health Company Detail
        11.8.2 Opko Health Business Overview
        11.8.3 Opko Health Next Generation Cancer Diagnostics Introduction
        11.8.4 Opko Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.8.5 Opko Health Recent Development
    11.9 Myriad Genetics
        11.9.1 Myriad Genetics Company Detail
        11.9.2 Myriad Genetics Business Overview
        11.9.3 Myriad Genetics Next Generation Cancer Diagnostics Introduction
        11.9.4 Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.9.5 Myriad Genetics Recent Development
    11.10 Agilent Technologies
        11.10.1 Agilent Technologies Company Detail
        11.10.2 Agilent Technologies Business Overview
        11.10.3 Agilent Technologies Next Generation Cancer Diagnostics Introduction
        11.10.4 Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.10.5 Agilent Technologies Recent Development
    11.11 GE Healthcare
        11.11.1 GE Healthcare Company Detail
        11.11.2 GE Healthcare Business Overview
        11.11.3 GE Healthcare Next Generation Cancer Diagnostics Introduction
        11.11.4 GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.11.5 GE Healthcare Recent Development
    11.12 PerkinElmer
        11.12.1 PerkinElmer Company Detail
        11.12.2 PerkinElmer Business Overview
        11.12.3 PerkinElmer Next Generation Cancer Diagnostics Introduction
        11.12.4 PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.12.5 PerkinElmer Recent Development
    11.13 Genomic Health
        11.13.1 Genomic Health Company Detail
        11.13.2 Genomic Health Business Overview
        11.13.3 Genomic Health Next Generation Cancer Diagnostics Introduction
        11.13.4 Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.13.5 Genomic Health Recent Development
    11.14 Illumina
        11.14.1 Illumina Company Detail
        11.14.2 Illumina Business Overview
        11.14.3 Illumina Next Generation Cancer Diagnostics Introduction
        11.14.4 Illumina Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.14.5 Illumina Recent Development
    11.15 Hologic
        11.15.1 Hologic Company Detail
        11.15.2 Hologic Business Overview
        11.15.3 Hologic Next Generation Cancer Diagnostics Introduction
        11.15.4 Hologic Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.15.5 Hologic Recent Development
    11.16 Almac Group
        11.16.1 Almac Group Company Detail
        11.16.2 Almac Group Business Overview
        11.16.3 Almac Group Next Generation Cancer Diagnostics Introduction
        11.16.4 Almac Group Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.16.5 Almac Group Recent Development
    11.17 Janssen Global Services
        11.17.1 Janssen Global Services Company Detail
        11.17.2 Janssen Global Services Business Overview
        11.17.3 Janssen Global Services Next Generation Cancer Diagnostics Introduction
        11.17.4 Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.17.5 Janssen Global Services Recent Development
    11.18 Sysmex Corporation
        11.18.1 Sysmex Corporation Company Detail
        11.18.2 Sysmex Corporation Business Overview
        11.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Introduction
        11.18.4 Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
        11.18.5 Sysmex Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Next Generation Sequencing
    Table 3. Key Players of qPCR & Multiplexing
    Table 4. Key Players of DNA Microarrays
    Table 5. Key Players of Others
    Table 6. Global Next Generation Cancer Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Next Generation Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Next Generation Cancer Diagnostics Market Share by Region (2017-2022)
    Table 10. Global Next Generation Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Next Generation Cancer Diagnostics Market Share by Region (2023-2028)
    Table 12. Next Generation Cancer Diagnostics Market Trends
    Table 13. Next Generation Cancer Diagnostics Market Drivers
    Table 14. Next Generation Cancer Diagnostics Market Challenges
    Table 15. Next Generation Cancer Diagnostics Market Restraints
    Table 16. Global Next Generation Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Next Generation Cancer Diagnostics Market Share by Players (2017-2022)
    Table 18. Global Top Next Generation Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2021)
    Table 19. Ranking of Global Top Next Generation Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Next Generation Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Next Generation Cancer Diagnostics Product Solution and Service
    Table 23. Date of Enter into Next Generation Cancer Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2017-2022)
    Table 27. Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2023-2028)
    Table 29. Global Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2017-2022)
    Table 31. Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2023-2028)
    Table 33. North America Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Cepheid Company Detail
    Table 44. Cepheid Business Overview
    Table 45. Cepheid Next Generation Cancer Diagnostics Product
    Table 46. Cepheid Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 47. Cepheid Recent Development
    Table 48. Koninklijke Philips N.V Company Detail
    Table 49. Koninklijke Philips N.V Business Overview
    Table 50. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product
    Table 51. Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 52. Koninklijke Philips N.V Recent Development
    Table 53. F. Hoffmann-La Roche Ltd Company Detail
    Table 54. F. Hoffmann-La Roche Ltd Business Overview
    Table 55. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product
    Table 56. F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 57. F. Hoffmann-La Roche Ltd Recent Development
    Table 58. Qiagen Company Detail
    Table 59. Qiagen Business Overview
    Table 60. Qiagen Next Generation Cancer Diagnostics Product
    Table 61. Qiagen Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 62. Qiagen Recent Development
    Table 63. Novartis AG Company Detail
    Table 64. Novartis AG Business Overview
    Table 65. Novartis AG Next Generation Cancer Diagnostics Product
    Table 66. Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 67. Novartis AG Recent Development
    Table 68. Abbott Company Detail
    Table 69. Abbott Business Overview
    Table 70. Abbott Next Generation Cancer Diagnostics Product
    Table 71. Abbott Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 72. Abbott Recent Development
    Table 73. Thermo Fisher Scientific Company Detail
    Table 74. Thermo Fisher Scientific Business Overview
    Table 75. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product
    Table 76. Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 77. Thermo Fisher Scientific Recent Development
    Table 78. Opko Health Company Detail
    Table 79. Opko Health Business Overview
    Table 80. Opko Health Next Generation Cancer Diagnostics Product
    Table 81. Opko Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 82. Opko Health Recent Development
    Table 83. Myriad Genetics Company Detail
    Table 84. Myriad Genetics Business Overview
    Table 85. Myriad Genetics Next Generation Cancer Diagnostics Product
    Table 86. Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 87. Myriad Genetics Recent Development
    Table 88. Agilent Technologies Company Detail
    Table 89. Agilent Technologies Business Overview
    Table 90. Agilent Technologies Next Generation Cancer Diagnostics Product
    Table 91. Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 92. Agilent Technologies Recent Development
    Table 93. GE Healthcare Company Detail
    Table 94. GE Healthcare Business Overview
    Table 95. GE Healthcare Next Generation Cancer DiagnosticsProduct
    Table 96. GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 97. GE Healthcare Recent Development
    Table 98. PerkinElmer Company Detail
    Table 99. PerkinElmer Business Overview
    Table 100. PerkinElmer Next Generation Cancer DiagnosticsProduct
    Table 101. PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 102. PerkinElmer Recent Development
    Table 103. Genomic Health Company Detail
    Table 104. Genomic Health Business Overview
    Table 105. Genomic Health Next Generation Cancer DiagnosticsProduct
    Table 106. Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 107. Genomic Health Recent Development
    Table 108. Illumina Company Detail
    Table 109. Illumina Business Overview
    Table 110. Illumina Next Generation Cancer DiagnosticsProduct
    Table 111. Illumina Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 112. Illumina Recent Development
    Table 113. Hologic Company Detail
    Table 114. Hologic Business Overview
    Table 115. Hologic Next Generation Cancer DiagnosticsProduct
    Table 116. Hologic Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 117. Hologic Recent Development
    Table 118. Almac Group Company Detail
    Table 119. Almac Group Business Overview
    Table 120. Almac Group Next Generation Cancer DiagnosticsProduct
    Table 121. Almac Group Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 122. Almac Group Recent Development
    Table 123. Janssen Global Services Company Detail
    Table 124. Janssen Global Services Business Overview
    Table 125. Janssen Global Services Next Generation Cancer DiagnosticsProduct
    Table 126. Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 127. Janssen Global Services Recent Development
    Table 128. Sysmex Corporation Company Detail
    Table 129. Sysmex Corporation Business Overview
    Table 130. Sysmex Corporation Next Generation Cancer DiagnosticsProduct
    Table 131. Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 132. Sysmex Corporation Recent Development
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Next Generation Cancer Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Next Generation Sequencing Features
    Figure 3. qPCR & Multiplexing Features
    Figure 4. DNA Microarrays Features
    Figure 5. Others Features
    Figure 6. Global Next Generation Cancer Diagnostics Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Next Generation Cancer Diagnostics Report Years Considered
    Figure 11. Global Next Generation Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Next Generation Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Next Generation Cancer Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Next Generation Cancer Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Next Generation Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Next Generation Cancer Diagnostics Revenue in 2021
    Figure 17. North America Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Next Generation Cancer Diagnostics Market Share by Country (2017-2028)
    Figure 19. United States Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Next Generation Cancer Diagnostics Market Share by Country (2017-2028)
    Figure 23. Germany Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Next Generation Cancer Diagnostics Market Share by Region (2017-2028)
    Figure 31. China Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Next Generation Cancer Diagnostics Market Share by Country (2017-2028)
    Figure 39. Mexico Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Next Generation Cancer Diagnostics Market Share by Country (2017-2028)
    Figure 43. Turkey Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Cepheid Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 46. Koninklijke Philips N.V Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 47. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 48. Qiagen Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 49. Novartis AG Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 50. Abbott Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 52. Opko Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 53. Myriad Genetics Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 54. Agilent Technologies Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 55. GE Healthcare Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 56. PerkinElmer Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 57. Genomic Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 58. Illumina Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 59. Hologic Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 60. Almac Group Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 61. Janssen Global Services Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 62. Sysmex Corporation Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Frequently Asked Questions
Next Generation Cancer Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Next Generation Cancer Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Next Generation Cancer Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports